Harvard Bioscience (HBIO) Net Income Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) Net Income Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.78 Bn | 43.96 Bn | 2.15 Bn |
| 3 | Alcon | 32.91 Bn | 31.25 Bn | 1.53 Bn |
| 4 | Medline | 32.82 Bn | 30.58 Bn | 1.84 Bn |
| 5 | Resmed | 29.56 Bn | 27.90 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.50 Bn | 23.06 Bn | 329.20 Mn |
| 7 | Solventum | 14.04 Bn | 13.48 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.78 Bn | 13.64 Bn | 735.40 Mn |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 26.75 Mn | 19.65 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.62% |
| Dec 31, 2025 | -31.78% |
| Sep 30, 2025 | -2.00% |
| Jun 30, 2025 | -7.63% |
| Mar 31, 2025 | -61.94% |
| Dec 31, 2024 | -8.13% |
| Dec 31, 2023 | -1.02% |
| Jun 30, 2023 | -99.18% |
| Mar 31, 2023 | -19.41% |
| Dec 31, 2022 | -29.55% |
| Sep 30, 2022 | -76.10% |
| Jun 30, 2022 | 59.30% |
| Mar 31, 2022 | -84.57% |
| Dec 31, 2021 | 23.41% |
| Sep 30, 2021 | 36.43% |
| Jun 30, 2021 | 9.54% |
| Mar 31, 2021 | -1.02% |
| Dec 31, 2020 | 47.12% |
| Sep 30, 2020 | -5.65% |
| Jun 30, 2020 | -45.54% |